New Classification Schemes based on FeDCLIP (female, diabetes, CLI, lesion length, poor-runoff) score of Clinical Outcome after Self-Expandable Nitinol Stenting in Superficial Femoral artery Trial

New Classification Schemes based on FeDCLIP (female, diabetes, CLI, lesion length, poor-runoff) score of Clinical Outcome after Self-Expandable Nitinol Stenting in Superficial Femoral artery Trial - FeDCLIP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004793

Enrollment

800

Registered

2010-12-27

Start date

2010-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

superficial femoral artery disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: successful self-expandable nitinol stenting for de novo superficial femoral lesions

Exclusion criteria

Exclusion criteria: Asymptomatic, age <40 years, a follow-up interval <6 months, treatment with angioplasty alone, restenotic lesions, use of a metallic stent, history of lower extremities bypass surgery or EVT, or acute onset limb ischemia.

Design outcomes

Primary

Measure	Time frame
primary patency	—

Secondary

Measure	Time frame
secondary patency all-cause mrtality	—

Countries

Japan

Outcome results